Tranexamic Acid Reduces Bleeding After Cardiopulmonary Bypass When Compared to Epsilon Aminocaproic Acid and Placebo

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of cardiac surgery

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1540-8191.1997.tb00147.xPMID 9635271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tranexamic acid significantly reduces blood loss associated with coronary revascularization.

  1995cited by this paper
• Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.

  1994cited by this paper
• Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting

  1994cited by this paper
• Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding.

  1994cited by this paper
• Prevention of postbypass bleeding with tranexamic acid and ϵ-aminocaproic acid

  1993cited by this paper
• Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest.

  1993cited by this paper
• Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom.

  1993cited by this paper
• Aprotinin therapy for reoperative myocardial revascularization: an opposing view.

  1993cited by this paper
• Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.

  1993cited by this paper
• Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement.

  1993cited by this paper
• High-dose aprotinin therapy: a review of the first five years' experience.

  1992cited by this paper
• The declining risk of post-transfusion hepatitis C virus infection.

  1992cited by this paper
• Natural and synthetic antifibrinolytics in cardiac surgery

  1992cited by this paper
• The effect of warm heart surgery on postoperative bleeding.

  1992cited by this paper
• The risk of transfusion-transmitted infection.

  1992cited by this paper
• Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery

  1991cited by this paper
• Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.

  1991cited by this paper
• Adverse haemodynamic effects of high‐dose aprotinin in a paediatric cardiac surgical patient

  1990cited by this paper
• Prophylactic tranexamic acid decreases bleeding after cardiac operations.

  1990cited by this paper
• Effects of plasmin (Pli) plasminogen activators (PAs) on surface expression of glycoprotein (GP) Ib and IIb-IIIa complex of human platelets

  1990cited by this paper
• Aprotinin (trasylol) is a competitive inhibitor of activated protein C.

  1989cited by this paper
• Prophylactic treatment of postperfusion bleeding using EACA.

  1989cited by this paper
• The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.

  1988cited by this paper
• Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients

  1988cited by this paper
• Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

  1987cited by this paper
• Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation

  1986cited by this paper
• Clinical Application of Inhibitors of Fibrinolysis

  1985cited by this paper
• Mediastinal infection after cardiac surgery.

  1984cited by this paper
• Late changes in hemostatic parameters following open-heart surgery.

  1982cited by this paper
• The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation.

  1975cited by this paper
• Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers

  1974cited by this paper
• The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease.

  1974cited by this paper
• Epsilon-aminocaproic acid for bleeding after cardiopulmonary bypass.

  1971cited by this paper
• Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients.

  1967cited by this paper
• Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients.

  1967cited by this paper
• OPEN HEART SURGERY.

  1964cited by this paper

• Efficacy and Safety Profile of Low-Dose Tranexamic Acid Regimen in Cardiac Surgery: A Meta-Analysis.

  2025cites this paper
• Efficacy of Epsilon Aminocaproic Acid Versus Placebo in Coronary Artery Bypass Graft: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma

  2023influential citation
• Comparison of trauma‐dosed tranexamic acid versus aminocaproic acid in cardiac surgery in the setting of drug shortage

  2022cites this paper
• Effectiveness and Safety of E-aminocaproic Acid in Overall and Less-Invasive Cardiac Surgeries.

  2022cites this paper
• Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review

  2021cites this paper
• Effects of Tranexamic Acid in Reducing Blood Loss in Patients Undergoing Coronary Artery Bypass Surgery: A Systematic Review

  2020cites this paper
• A Randomized, Double-Blinded Trial Comparing the Effectiveness of Tranexamic Acid and Epsilon-Aminocaproic Acid in Reducing Bleeding and Transfusion in Cardiac Surgery

  2019cites this paper
• Caproamin Fides® Versus Transamin® in High Risk Patients Undergoing CABG

  2019cites this paper
• Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials

  2019cites this paper
• Prospective , Randomized Trial Acid in Posterior Spinal Fusion for Spinal Deformity : A A Comparison of Two Different Dosing Protocols for Tranexamic

  2019cites this paper
• Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta‐analysis

  2018cites this paper
• The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis.

  2018cites this paper
• Intraoperative Management of Adult Lumbar Scoliosis

  2017cites this paper
• Comparison of epsilon aminocaproic acid and tranexamic acid to control postoperative bleeding in patients undergoing mitral valve replacement surgery-A randomised double blind trial

  2017influential citation
• Aminocaproic vs. tranexamic acid in cardiac surgery: what? where? when? Part 2

  2016cites this paper
• Comparative effectiveness of epsilon-aminocaproic acid and tranexamic acid on postoperative bleeding following cardiac surgery during a national medication shortage.

  2016cites this paper
• Intravenous Tranexamic Acid Decreases Allogeneic Transfusion Requirements in Periacetabular Osteotomy.

  2016cites this paper
• Аминокапроновая или транексамовая кислота в кардиохирургии: что? где? когда? Обзор литературы. Часть 2

  2016cites this paper
• A Comparison of Two Different Dosing Protocols for Tranexamic Acid in Posterior Spinal Fusion for Spinal Deformity: A Prospective, Randomized Trial

  2015cites this paper
• Uso do ácido tranexâmico no controle do sangramento em cirurgias de escoliose toracolombar com instrumentação posterior

  2015cites this paper
• Repository Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery ?

  2015cites this paper
• Use of tranexamic acid for controlling bleeding in thoracolumbar scoliosis surgery with posterior instrumentation

  2015cites this paper
• Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding

  2015cites this paper
• Systematic review, meta‐analysis and meta‐regression of the effect of tranexamic acid on surgical blood loss

  2013cites this paper
• Cost Comparisons of Pharmacological Strategies in Open-Heart Surgery

  2012cites this paper
• Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis

  2012cites this paper
• Does the Intraoperative Tranexamic Acid Decrease Operative Blood Loss During Posterior Spinal Fusion for Treatment of Adolescent Idiopathic Scoliosis?

  2012cites this paper
• Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial.

  2012cites this paper
• Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

  2011cites this paper
• A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery

  2010cites this paper
• Anesthetic experience of aortic valve replacement, tricuspid valvuloplasty and VSD closure in a patient with Child-Pugh class B liver cirrhosis : A case report.

  2009cites this paper
• [Antifibrinolytics and cardiac surgery with cardiopulmonary bypass.].

  2007cites this paper
• Antifibrinolíticos e Cirurgia Cardíaca com Circulação Extracorpórea* Antifibrinolytics and Cardiac Surgery with Cardiopulmonary Bypass

  2007cites this paper
• A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.

  2006cites this paper
• Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials

  2005cites this paper
• Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery?

  2004cites this paper
• Cardiopulmonary Bypass-Associated Coagulopathies and Prophylactic Therapy

  2004cites this paper
• Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery

  2003cites this paper
• Pharmacokinetics of Tranexamic Acid during Cardiopulmonary Bypass

  2002cites this paper
• Pharmacological Strategies to Decrease Excessive Blood Loss in Cardiac Surgery: Meta‐analysis of Clinically Relevant Endpoints*

  2001cites this paper
• Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

  1999cites this paper
• Prevention of Ischemic Injury in Cardiac Surgery

  year unknowncites this paper